Nuno Costa

1.7k total citations
18 papers, 191 citations indexed

About

Nuno Costa is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nuno Costa has authored 18 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 7 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nuno Costa's work include Bladder and Urothelial Cancer Treatments (9 papers), Renal cell carcinoma treatment (6 papers) and Urinary and Genital Oncology Studies (5 papers). Nuno Costa is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Renal cell carcinoma treatment (6 papers) and Urinary and Genital Oncology Studies (5 papers). Nuno Costa collaborates with scholars based in Italy, United Kingdom and France. Nuno Costa's co-authors include Thomas Powles, Petros Grivas, Yohann Loriot, Fernando Pardal, Joaquim Bellmunt, Erika Matos, Robert J Laliberte, Srikala S. Sridhar, Cora N. Sternberg and Daniel P. Petrylak and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Nuno Costa

16 papers receiving 189 citations

Peers

Countries citing papers authored by Nuno Costa

Since Specialization

Citations

This map shows the geographic impact of Nuno Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuno Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuno Costa more than expected).

Fields of papers citing papers by Nuno Costa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuno Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuno Costa. The network helps show where Nuno Costa may publish in the future.

Co-authorship network of co-authors of Nuno Costa

This figure shows the co-authorship network connecting the top 25 collaborators of Nuno Costa. A scholar is included among the top collaborators of Nuno Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuno Costa. Nuno Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Nurses’ Interventions in Minimizing Adult Patient Vulnerability During Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation: An Integrative Review 2024 ·SAGE Open Nursing ·Nuno Costa, Helga Rafael Henriques, (unknown)	0
2	Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial 2023 ·European Urology ·Petros Grivas, Se Hoon Park, Éric Voog, Claudia Caserta, Howard Gurney, Joaquim Bellmunt, Haralabos P. Kalofonos, Anders Ullén, Yohann Loriot, Srikala S. Sridhar, Yoshiaki Yamamoto, Daniel P. Petrylak, Cora N. Sternberg, Shilpa Gupta, Bo Huang, Nuno Costa, Robert J Laliberte, Alessandra di Pietro, Begoña P. Valderrama, Thomas Powles	30
3	Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance 2023 ·European Urology ·Srikala S. Sridhar, Thomas Powles, Miguel Á. Climent Durán, Se Hoon Park, Francesco Massari, Antoine Thiery-Vuillemin, Begoña P. Valderrama, Anders Ullén, Norihiko Tsuchiya, Jeanny B. Aragon‐Ching, Shilpa Gupta, Daniel P. Petrylak, Joaquim Bellmunt, Jing Wang, Robert J Laliberte, Alessandra di Pietro, Nuno Costa, Petros Grivas, Cora N. Sternberg, Yohann Loriot	11
4	Evaluating Real-World Characteristics of Patients With Advanced Urothelial Carcinoma Eligible for Avelumab Maintenance Therapy: A Multicountry Retrospective Medical Chart Review 2023 ·Clinical Genitourinary Cancer ·Joaquim Bellmunt, Jane Chang, (unknown), Joseph C. Cappelleri, Nuno Costa, Elizabeth Esterberg, Mairead Kearney, (unknown), Sean D. Candrilli, Mayank Ajmera	4
5	Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Long-term follow-up results from the JAVELIN Bladder 100 trial. 2022 ·Journal of Clinical Oncology ·Thomas Powles, Se Hoon Park, Éric Voog, Claudia Caserta, Begoña Pérez‐Valderrama, Howard Gurney, Yohann Loriot, Srikala S. Sridhar, Norihiko Tsuchiya, Cora N. Sternberg, Joaquim Bellmunt, Jeanny B. Aragon‐Ching, Daniel P. Petrylak, Andy Blake-Haskins, Robert J Laliberte, Jing Wang, Nuno Costa, Petros Grivas	20
6	Criteria used to determine platinum eligibility and first-line (1L) treatment (tx) patterns among platinum-eligible (PE) and -ineligible (PI) patients (pts) with metastatic urothelial cancer (mUC) in France, Germany, Spain, Italy, and the United Kingdom (Eu5). 2022 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Mairead Kearney, Nuno Costa, Jane Chang	2
7	Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program 2021 ·Journal of Translational Medicine ·Giovanni Grignani, Vanna Chiarion‐Sileni, Carmine Pinto, Roberta Depenni, Nicola Fazio, Luca Galli, Dario Giuffrida, Carlo Carnaghi, Domenico Ciliberto, Domenico Corsi, Paola Queirolo, Elena Benincasa, Filippo Venturini, (unknown), Nuno Costa, Paolo A. Ascierto	4
8	Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East 2021 ·International Journal of Cancer ·Paolo A. Ascierto, (unknown), Giovanni Grignani, (unknown), Eyal Fenig, Vanna Chiarion‐Sileni, Nicola Fazio, M. Samimi, Laurent Mortier, Christoffer Gebhardt, N. Kramkimel, Neil Steven, Oliver Bechter, Ana Arance, Elena Benincasa, (unknown), Nuno Costa, Paul Lorigan	8
9	Avelumab (Ave) first-line (1L) maintenance plus best supportive care (BSC) versus BSC alone for advanced urothelial carcinoma (UC): JAVELIN Bladder 100 subgroup analysis based on duration and cycles of 1L chemotherapy. 2021 ·Journal of Clinical Oncology ·Yohann Loriot, Thomas Powles, Miguel Á. Climent Durán, Srikala S. Sridhar, Joaquim Bellmunt, Daniel P. Petrylak, Jing Wang, Nuno Costa, Robert J Laliberte, Alessandra di Pietro, Petros Grivas, Cora N. Sternberg	12
10	Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC) in the JAVELIN Bladder 100 trial: Subgroup analysis by duration of treatment-free interval (TFI) from end of chemotherapy to start of maintenance. 2021 ·Journal of Clinical Oncology ·Srikala S. Sridhar, Thomas Powles, Yohann Loriot, Miguel Á. Climent Durán, Shilpa Gupta, Norihiko Tsuchiya, Aristotelis Bamias, Andrea Ardizzoni, Anders Ullén, Bo Huang, Nuno Costa, Robert J Laliberte, Alessandra di Pietro, Cora N. Sternberg, Petros Grivas	10
11	Avelumab first-line (1L) maintenance plus best supportive care (BSC) versus BSC alone for advanced urothelial carcinoma (UC): Analysis of time to end of next-line therapy in JAVELIN Bladder 100. 2021 ·Journal of Clinical Oncology ·Petros Grivas, Se Hoon Park, Éric Voog, Evgeny Kopyltsov, Howard Gurney, David Queiroz Borges Muniz, Frédéric Rolland, Anne Birgitte Als, Begoña P. Valderrama, Jing Wang, Nuno Costa, Robert J Laliberte, Alessandra di Pietro, Thomas Powles, Joaquim Bellmunt	4
12	Real-world Experience With Sunitinib Treatment in Patients With Metastatic Renal Cell Carcinoma: Clinical Outcome According to Risk Score 2020 ·Clinical Genitourinary Cancer ·Manuela Schmidinger, Camillo Porta, Stéphane Oudard, (unknown), Y. Brault, Lucile Serfass, Nuno Costa, James Larkin	12
13	704MO Avelumab first-line (1L) maintenance + best supportive care (BSC) vs BSC alone with 1L chemotherapy (CTx) for advanced urothelial carcinoma (UC): Subgroup analyses from JAVELIN Bladder 100 2020 ·Annals of Oncology ·Petros Grivas, S.H. Park, Éric Voog, Claudia Caserta, Begoña P. Valderrama, Howard Gurney, Haralabos P. Kalofonos, Siniša Radulović, Wim Demey, Anders Ullén, Yohann Loriot, Srikala S. Sridhar, Norihiko Tsuchiya, Evgeny Kopyltsov, Shilpa Gupta, Bo Huang, Nuno Costa, John A. Blake-Haskins, Alessandra di Pietro, Thomas Powles	10
14	Real-world experience with sunitinib treatment in patients with metastatic renal cell carcinoma: Clinical outcome according to risk score. 2019 ·Journal of Clinical Oncology ·Manuela Schmidinger, Camillo Porta, Stéphane Oudard, (unknown), Y. Brault, Lucile Serfass, Nuno Costa, James Larkin	5
15	Recomendações para o seguimento do doente tratado por cancro colorectal 2004 ·SHILAP Revista de lepidopterología ·Nuno Costa, (unknown), (unknown), Maria Fragoso, (unknown)	1
16	Mutations in exon 14 of dihydropyrimidine dehydrogenase and 5-Fluorouracil toxicity in Portuguese colorectal cancer patients 2004 ·Genetics in Medicine ·(unknown), Isabel Veiga, Maria Fragoso, (unknown), Nuno Costa, (unknown), (unknown), (unknown), Manuel R. Teixeira, Sérgio Castedo	30
17	Secretory breast carcinoma—case report and review of the medical literature 2004 ·The Breast ·Nuno Costa, (unknown), (unknown), Fernando Pardal, Erika Matos	25
18	411 Highly sensitive detection of the MGB1 transcript(mammaglobin) in the peripheral blood of breast cancer patients 2003 ·European Journal of Cancer Supplements ·Nuno Cerveira, L. Torres, Patrícia Rocha, Susana Bizarro, (unknown), Nuno Costa, (unknown), Rui Henrique, Manuel R. Teixeira, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact